More about
Epithelial Tumor
News
September 04, 2020
1 min read
Save
FDA grants orphan drug designation to KN046 for thymic epithelial tumors
The FDA granted orphan drug designation to KN046 for the treatment of patients with thymic epithelial tumors, according to a manufacturer-issued press release.